Address

OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States

Open map


Recent investment activity

KANDO id: 29979

Corporate information

Founders
Official name
OrbiMed Advisors Limited Liability Company
Registration country

Company type

American investment firm focused on making public and private investments in the healthcare and biotechnology industries.

Overview

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.



Funding rounds

Investment preferences

Investment focus themes
Top investment portfolio themes

Actual initial investment stage
N/A (2)
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 114
Profile Country Date Funding
Insulet Corp N/A
Vivus Inc N/A
Triangle Pharmaceuticals Inc Anti-viral and oncology licensing company. N/A
Caliper Life Sciences Inc N/A
XenoPort Inc N/A Initial investment
ARYx Therapeutics Inc N/A Initial investment
Anthera Pharmaceuticals Inc N/A
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series B
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series D
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series C
Avalon Pharmaceuticals Inc Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. N/A
EUSA Pharma Inc Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care Venture
Orphan Medical Inc N/A
Amarin Pharmaceuticals Inc N/A
NxStage Medical Inc Hemofiltration for kidney failure N/A
Sientra Inc Medical device company Series C
Vessix Vascular Inc Developing novel radiofrequency balloon catheter technology. N/A
ViewRay Inc [] A medical device company, develops advanced radiation therapy solutions for the treatment of cancer. N/A
RDD Pharma Ltd Drug-device company that developed an intra-anal drug delivery device. N/A
Adolor Corp N/A
Connetics Corp N/A
Agensys Inc Series D
Cell Therapeutics Inc Biotherapeutics for cancer treatment. N/A
superDimension Ltd Diagnose and potentially treat lung disease and lung cancer. N/A
Affimed Therapeutics AG Antibody therapeutics for cancer and inflammatory diseases. N/A

Past employees

Selected Products / Customers

Financials